Global Conjugate Vaccines Market Size study & Forecast, and Regional Analysis, 2022-2029

by Type (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines) by Disease Indication (Pneumococcal, Influenza, Diphtheria Tetanus and Pertussis (DTP), Meningococcal, Others), by Pathogen Type (Bacterial Conjugate Vaccine, Viral Conjugate Vaccine, Combination (Viral and Bacterial) Conjugate Vaccine), by End User (Pediatrics, Adults)

Published	Pages	Publisher	Report code
Feb 2023	200	Bizwit Research	ASDR-615975

Published: Feb 2023 - Pages : 200 - Publisher : Bizwit Research - Report code : ASDR-615975

Novartis AG
Neuron Biotech
Serum Institute of India
Pfizer Inc.
Sanofi Pasteur
Bharat Biotech
Biological E Ltd.
GlaxoSmithKline
plc.
Merck and Company
CSL Limited

Tetanus Toxoid Vaccine Market Size - By Vaccine Type (Tetanus Toxoid (TT), Diphtheria and Tetanus (DT), Tetanus and Diphtheria (Td), Pentavalent, & Diphtheria, Tetanus, and Pertussis (DTaP)), Age Group (Pediatric, Adult), End-use & Forecast, 2024 - 2032

This report can be of interest as well:

Tetanus Toxoid Vaccine Market Size - By Vaccine Type (Tetanus Toxoid (TT), Diphtheria and Tetanus (DT), Tetanus and Diph...

Published: February, 2024 | Report code: ASDR-665442

Mark your calendar:

Pre-filled Syringes West Coast Conference 2024

10 June - 11 June, 2024
San Diego, United States